FDA Moves Forward on Ecstasy Ingredient Trials for PTSD

The active ingredient in the drug ecstasy passed an important hurdle on the path to becoming a prescription drug for treating post-traumatic stress disorder.

via Live Science http://ift.tt/2xHIciA